HHR Asset Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-227,318
Closed -$5.94M 9
2022
Q1
$5.94M Buy
227,318
+8,034
+4% +$228K 1.08% 27
2021
Q4
$8.69M Sell
219,284
-53,915
-20% -$2.46M 1.04% 28
2021
Q3
$13.7M Sell
273,199
-2,035
-0.7% -$111K 1.44% 29
2021
Q2
$15.3M Sell
275,234
-42,210
-13% -$2.25M 1.38% 29
2021
Q1
$14.8M Sell
317,444
-108,219
-25% -$5.24M 1.34% 26
2020
Q4
$18.5M Buy
425,663
+13,240
+3% +$488K 1.58% 21
2020
Q3
$15.1M Buy
+412,423
New +$14M 1.5% 27

Other funds holding HCAT

HHR Asset Management's HCAT Position: Q2 2022 in Review

HHR Asset Management sold out of Health Catalyst (HCAT) in Q2 2022, closing a stake of 227,318 shares — an estimated $5.94M sold.

HHR Asset Management first reported a position in HCAT in Q3 2020 and held it in 7 quarters. The position peaked at $18.5M in Q4 2020. 180 funds tracked by Wall St. Rank hold HCAT as of Q2 2022.

  • HHR Asset Management reported no remaining Health Catalyst position as of Q2 2022 after selling out during the quarter.
  • HHR Asset Management sold 227,318 Health Catalyst shares in Q2 2022, an estimated $5.94M.
  • HHR Asset Management first reported a position in Health Catalyst in Q3 2020 and held it in 7 quarters.
  • HHR Asset Management's Health Catalyst position peaked at $18.5M in Q4 2020.
  • 180 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2022.

Based on HHR Asset Management's 13F filing for Q2 2022.